Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Oral Anti-inflammatory, Analgesic for Horses Nature Vet Data Sheet Cu-Algesic Equine Granules and Paste Oral, Non-Steroidal Anti-Inflammatory (NSAID) with low gastro-intestinal toxicity and rapid excretion COMPOSITION Cu-Algesic is a patented chelate formulation of Copper Indomethacin, available as: Cu-Algesic Equine Oral Paste Anti-Inflammatory for Horses: Active constituent: Copper indomethacin 40 mg/g Cu-Algesic Granules: Active constituent: Copper indomethacin 10 mg/g ACTIONS Cu-Algesic is a potent non-steroidal anti-inflammatory and analgesic for the treatment of acute and sub-acute musculoskeletal / locomotor inflammatory conditions in horses. Cu-Algesic provides excellent analgesia, as well as potent antiinflammatory activity, with very low gastro-intestinal toxicity, unlike most other NSAIDs. Cu-Algesic is the only NSAID known to be a free radical scavenger. Cu-Algesic has a once daily dosage regime, plus predictable short excretion rates, even with repeated dosing. INDICATIONS Cu-Algesic is indicated for conditions requiring a potent antiinflammatory action with excellent analgesia, with reduction of side effects usually associated with long term use of other NSAIDs. These conditions include acute and sub-acute musculoskeletal / locomotor inflammatory conditions such as osteitis (shin soreness), pedal osteitis, navicular disease, sesamoiditis, synovial arthritis, osteoarthritis, bursitis, tenosynovitis, spondylitis, tendonitis and ligament inflammation, and ocular conditions such as uveitis. Copper chelation of the parent NSAID (Indomethacin) produces a unique pharmacological substance with significantly increased anti-inflammatory potency, broader inhibition of inflammatory reactions, and virtual elimination of adverse side effects, especially gastro-intestinal ulceration. Copper indomethacin is a prostaglandin cyclo-oxygenase 1 & 2 (Cox 1 & 2) inhibitor. Additionally, the lipoxygenase pathway is inhibited. It also inhibits kallikreins, and thereby bradykinin formation, which, with histamine and prostaglandins, produce the pain of inflammation. Copper chelates are free radical scavengers by Superoxide Dismutase mimetic activity. Superoxide free radicals are involved in degradation of hyaluronic acid in inflamed joints and in perpetuation of the inflammatory cycle. Copper indomethacin is therefore ideal for use in joint disease, and is indicated for prevention of reperfusion injury. The broad combination of modes of action helps to reduce gastro-intestinal and renal toxicity. Cu-Algesic is rapidly absorbed from the gastro-intestinal tract. Peak plasma levels are achieved within 3 - 4 hours of administration. Plasma half-life of Cu-Algesic in the horse is approximately 24 hours. Cu-Algesic is rapidly and predictably excreted, provided hepatic and renal function are normal. Copper indomethacin may be used with caution as subsequent oral NSAID therapy following parenteral treatment with other NSAIDs (e.g. phenylbutazone or salicylates). There is no evidence of either synergy or antagonism between copper indomethacin and other NSAIDs. Use of two NSAIDs together generally summate therapeutic and toxic effects, and extends clearance times. Renal or hepatic conditions may alter the pharmacokinetics. DOSAGE AND ADMINISTRATION Cu-Algesic Granules: 1 level scoop equals 20 g. Give 40 g/450 kg bodyweight on food initially, then 20 - 40 g once daily thereafter. Cu-Algesic Equine Paste: Plunger is marked in 5 g increments Give 10 g / 500 kg bodyweight by direct oral dosing initially, then 5 g / 500 kg once daily thereafter (i.e. 1 g per 100 kg bodyweight once daily) WARNINGS Safety in young foals or during pregnancy has not been conclusively demonstrated, and veterinarians should exercise normal caution in prescribing anti-inflammatories during these times. Meat Withholding Period (Horses): DO NOT USE less than 28 days before slaughter for human consumption. PRESENTATION Paste: 40 mg/g, 30 g oral paste syringe (5 day course) Granules: 10 mg/g, 200 g tub (10 day course) STORAGE Store below 25˚C (Air Conditioning). Protect from moisture. AVAILABILITY S4 - By Veterinary Prescription (APVMA 56262 [Paste], 40301 [Granules]) Freecall (Australia) 1800 624 174 Telephone (+61) 2 9652 7000 Web: www.naturevet.com